Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

45.21USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$45.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
218,335
52-wk High
$91.75
52-wk Low
$41.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
FY 2015 Dec '15 17.20 -0.250
Sep '15 1.30 -0.700
Jun '15 1.29 -0.595
Mar '15 2.27 -0.578
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 17 7.56 21.30 0.00 14.70
Quarter Ending Mar-18 11 6.33 26.50 0.00 --
Year Ending Dec-17 18 11.80 25.96 3.00 25.04
Year Ending Dec-18 18 94.08 223.80 32.20 187.92
Earnings (per share)
Quarter Ending Dec-17 17 -1.71 -1.24 -2.00 -1.00
Quarter Ending Mar-18 10 -1.80 -1.33 -1.99 --
Year Ending Dec-17 17 -7.59 -7.19 -7.99 -4.34
Year Ending Dec-18 18 -5.53 -2.14 -7.69 -1.27
LT Growth Rate (%) 1 13.00 13.00 13.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 153.83 100.67 5.40
Price to Book (MRQ) 11.96 13.50 5.38
Price to Tangible Book (MRQ) 13.80 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 83.26 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.10 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -3.39 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.91 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -116.29 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 6.09 5.36 2.98
LT Debt to Equity (MRQ) 0.47 18.92 11.56
Total Debt to Equity (MRQ) 0.60 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -816.79 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -984.26 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -973.11 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -962.76 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,602 25,314,503 864,673,321
Net Income/Employee (TTM) -920,417 3,332,048 101,717,508
Receivable Turnover (TTM) 6.52 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.06 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.26 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -61.15 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -63.88 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.35 2.68 66 53
13 Week 41.42 34.53 87 61
26 Week 71.05 58.05 91 69
52 Week 44.55 22.52 76 46
YTD 75.23 53.89 83 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 97.81%
# of Holders: 248
Total Shares Held: 36,194,162
3 Mo. Net Change: 6,601,931
# New Positions: 52
# Closed Positions: 16
# Increased Positions: 155
# Reduced Positions: 48
# Net Buyers: 107
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.